Recent Finacing
Recent Raise
Cora Therapeutics develops DNA HALO, a patented antioxidant formulation protecting cellular and mitochondrial DNA from medical and nuclear radiation, developed with Canadian university partners and compliant with U.S./Canadian regulations.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor